Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, making noteworthy gains. So far in 2015, several industries have either underperformed or provided mixed results, leading to a rather ho-hum showpiece for U.S. blue-chip indices.Biotech stocks, on the other hand, have consistently returned positive results in the markets over the past […]
Many individual investors have opted to invest in biotech ETFs and mutual funds. The XBI and SBIO funds have performed well because they focus more on small and mid-sized biotech companies. The IBB, which has emerged as something of a proxy for the industry for many investors, is weighted much more heavily to bigger, more proven biotech companies.The volatility of […]
The enticing if volatile biotechs continue to intrigue investors. Some of the stocks in the fast-growing sector are more alluring than many others, but make no mistake: Biotechs should not be ignored!“Biotech stocks are still in favor with investors for all the right reasons: constant M&A, solid clinical data, regulatory reviews, upcoming scientific conferences, selective stock picking, and technical support,” […]
LONDON, March 19, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Cytori Therapeutics Inc. (NASDAQ: CYTX), Oncolytics Biotech Inc. (NASDAQ: ONCY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Aeterna Zentaris Inc. (NASDAQ: AEZS), and Immunomedics Inc. (NASDAQ: IMMU). Free research report on Cytori Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Cytori%20Therapeutics&d=19-Mar-2015&s=CYTX. […]
The stock market has been racing higher at nearly unprecedented levels in recent years. Even so, the healthcare sector in general, and biopharma stocks in particular, have still managed to crush the broader markets over the last few years. Since 2012, for instance, the iShares Nasdaq Biotech Index has more than tripled the returns of the closely watched S&P 500:Perhaps […]
In last week’s Benzinga article on InterMune (NASDAQ: ITMN), some of the warning signs for the overall stock market were highlighted.Those warnings became more than just warnings last week, as the market took some significant hits. Last Thursday’s 300-plus drop on the Dow Jones Industrial Average was the main headline.Since then the market has continued to decline, but some stocks […]
The Association of the British Pharmaceutical Industry (ABPI) has published a road map to accelerate progress on harnessing the power of ‘big data’.
The move comes as all parties involved in healthcare find themselves in an exploding bioinformatics and data environment, which many believe will be a key driver for change over the next decade, improving patient care and putting the […]
